09.11.26 -- The Complex Anatomy Of An ADC Tech Transfer

Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers.

Modernizing biomanufacturing requires shifting from rigid, custom setups toward modular automation, data-rich sensors, and plug-and-produce operations. 

Strong package integrity starts with a clear view of risk. Learn how science, validation, quality, and manufacturing considerations can work together to support a stronger CCI strategy.

What is critical when choosing a CDMO as a partner for HPAPI development and manufacturing? Brian Haney breaks down the key questions, controls, and expertise every innovator should evaluate.

Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges.

Predict ibuprofen softgel shelf life in 21 days. ASAPprime modeling identified PEG-ester degradants as the limiting factor, estimating 5.5-year and 3.8-year shelf lives before studies concluded.

As capacity expands and capabilities mature, CDMOs with global scale and advanced injectable expertise are becoming critical partners for bringing complex sterile drug products to market.

Nearly 90% of marketed drugs have poor water solubility. See how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.

Medical device coatings are shifting from basic finishes to strategic tools that boost performance, safety, sustainability, and innovation through stronger partnerships and smarter materials.

Product recalls impact revenue and reputation. Implementing inspection systems like X-ray, vision inspection, and metal detection helps prevent contamination, ensuring high product quality.

Gain insights into how expert teams and the right tools help build resilience into manufacturing systems and tackle small, often-overlooked issues before they become costly problems.

Unlock the keys to consistent solid dosage products. Align unique product needs with optimal processing requirements and equipment strategies. Gain a roadmap for improved quality and reproducibility.

Pharma 4.0™ leverages IoT, AI, and automation to enhance drug quality. Evaluate your fill-finish line readiness by considering five key questions on modularity and high-risk process automation.